10-Q: CoreCivic Reports Strong Q1 2026 Results Driven by Federal Contracts

Sentiment:

Quarterly Report


CoreCivic, Inc. announced a significant increase in net income and revenue for the first quarter of 2026, primarily driven by expanded federal contracts and improved occupancy rates.

Capital raiseThe company amended its Bank Credit Facility to increase the revolving credit capacity from $275.0 million to $575.0 million.On April 10, 2026, the company obtained an Incremental Term Loan of $100.0 million, using the proceeds to pay down the Revolving Credit Facility and for general corporate purposes.
Better than expectedRevenue significantly exceeded prior year levels, driven by strong federal contract performance and increased occupancy.Net income saw a substantial increase, indicating improved profitability.The company successfully activated previously idled facilities, contributing to revenue growth and demonstrating operational flexibility.The acquisition of CSP is a positive strategic move that is expected to diversify revenue streams.

Summary

  • CoreCivic reported a net income of $37.9 million for the first quarter of 2026, a substantial increase from $25.1 million in the same period of 2025.
  • Total revenue grew by 25.8% to $614.7 million, largely due to a 48.4% surge in federal revenue, primarily from ICE contracts.
  • Average daily compensated population increased by 11.3% to 57,243, driven by the activation of several previously idled facilities and increased ICE detainee numbers.
  • Operating expenses rose by 25.2% to $467.7 million, attributed to wage increases, higher staffing levels, and start-up expenses for newly activated facilities.
  • The company completed the acquisition of Clinical Solutions Pharmacy (CSP) on April 1, 2026, for approximately $148.0 million, diversifying its business.
  • CoreCivic amended its Bank Credit Facility to increase the revolving credit capacity and obtained an Incremental Term Loan of $100.0 million.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, with significant revenue and profit growth driven by increased government contracts and successful facility activations, alongside strategic acquisitions.

Positives

  • Significant increase in net income to $37.9 million from $25.1 million year-over-year.
  • Robust revenue growth of 25.8% to $614.7 million, driven by a substantial 48.4% increase in federal revenue.
  • Improved average daily compensated population by 11.3% to 57,243, indicating higher facility utilization.
  • Successful activation of five previously idled facilities contributing to increased capacity and revenue.
  • Strategic acquisition of Clinical Solutions Pharmacy (CSP) to diversify revenue streams.
  • Expansion of credit facilities providing enhanced financial flexibility.
  • Positive operating income per compensated man-day increase in both Safety and Community segments.
  • CoreCivic remains in compliance with all financial covenants under its Bank Credit Facility.

Negatives

  • Operating expenses increased by 25.2% to $467.7 million, outpacing revenue growth slightly, due to wage increases and start-up costs.
  • Cash provided by operating activities decreased to $13.8 million from $44.5 million year-over-year, primarily due to changes in working capital.
  • Potential for decreased utilization of facilities if ICE seeks alternative detention methods.
  • The Elizabeth Detention Center contract is on short-term extensions, with uncertainty regarding a long-term renewal and lease extension.

Risks

  • Changes in government policy, legislation, and regulations affecting the utilization of private sector facilities.
  • Dependence on government appropriations and potential for contract renegotiations or terminations.
  • Fluctuations in occupancy levels, competition, and increases in operating costs, including labor.
  • Government budget uncertainty, debt ceilings, and government shutdowns can impact contract renewals and payments.
  • Potential for negative publicity and inmate disturbances.
  • Litigation risks, including the ongoing class action lawsuit regarding ICE detainee labor and related matters.
  • The potential impact of injunctive relief sought in the California City facility litigation could negatively affect financial performance.
  • Uncertainty regarding the renewal of the Elizabeth Detention Center contract and its associated lease.

Future Outlook

CoreCivic anticipates continued growth opportunities, particularly from federal partners, due to the current administration's commitment to border security and deportation. The company expects increased demand for correctional and detention facilities, potentially leading to higher utilization of existing capacity and activation of idle facilities. The acquisition of CSP is expected to diversify cash flows in a complementary and growing market. Capital expenditures are projected to be $40.0 million to $45.0 million in 2026, with increased flexibility for share repurchases and other growth opportunities.

Management Comments

  • We believe the short-term growth opportunities of our business are particularly attractive as federal government agencies consider their emergent needs.
  • We currently expect average daily compensated populations to continue to increase in 2026 as a result of these new contracts.
  • We expect demand from the federal government for correctional and detention facilities in our Safety segment will ultimately increase from its current levels, particularly from ICE, as a result of changes in immigration policy and funding levels of our federal government partners charged with correctional and detention responsibilities.
  • We expect the acquisition of CSP to diversify our cash flows in a complementary business and a growing market.

Industry Context

StockSavvy.ai notes that CoreCivic's strong performance in Q1 2026 aligns with broader trends of increased federal government demand for correctional and detention services, driven by immigration policies. The company's strategic acquisitions and facility activations demonstrate a proactive approach to capitalizing on these market shifts, positioning it favorably within the private corrections and detention industry.

Comparison to Industry Standards

  • CoreCivic's revenue per compensated man-day of $116.53 in Q1 2026 shows an increase from $102.71 in Q1 2025, reflecting successful per diem adjustments and a favorable business mix, which is generally in line with or above industry benchmarks for similar services.
  • The operating margin of 24.0% for all facilities in Q1 2026 is a strong indicator of operational efficiency, comparing favorably to industry averages which can fluctuate based on contract types and government funding levels.
  • The company's ability to activate previously idled facilities and secure new contracts, such as with ICE for multiple facilities, demonstrates agility and responsiveness to government needs, a key differentiator in the industry.
  • The acquisition of CSP, a major provider of mail order pharmacy services to correctional facilities, is a strategic move to diversify revenue and expand service offerings, a trend seen among larger players seeking to enhance their value proposition.

Legal Proceedings

  • Class action lawsuit filed by former ICE detainees alleging forced labor and violation of labor laws at the Otay Mesa Detention Center.
  • Putative class action case filed by ICE detainees seeking injunctive relief related to the operation of the California City facility.
  • The company is cooperating with a Department of Justice investigation into conditions at the Trousdale Turner Correctional Center.

Stakeholder Impact

  • Shareholders are likely to benefit from increased profitability and potential for future growth driven by expanded government contracts and strategic acquisitions.
  • Employees may see increased employment opportunities due to facility activations and the acquisition of CSP, though wage pressures remain a factor.
  • Government partners benefit from CoreCivic's expanded capacity and services to meet correctional and detention needs.
  • Creditors are impacted by the company's increased borrowing capacity and ongoing debt management.

Next Steps

  • Continue to monitor and capitalize on increased demand from federal government agencies, particularly ICE.
  • Integrate the acquired Clinical Solutions Pharmacy (CSP) business.
  • Manage start-up expenses related to newly activated facilities.
  • Continue to pursue growth opportunities, including potential acquisitions and new development projects.
  • Manage debt obligations and utilize available credit facilities for strategic purposes.

Key Dates

DateDescription
2025-01-01Start of period for which financial data is compared (Q1 2025)
2025-03-31End of period for which financial data is compared (Q1 2025)
2025-07-01Acquisition of Farmville Detention Center
2025-09-29Announcement of new two-year contract with ICE for California City facility
2025-10-01Award of new contract for Diamondback Correctional Facility
2025-11-10Increase to share repurchase program authorization
2025-12-01Amendment to Bank Credit Facility to increase revolving credit capacity
2026-01-01Start of current reporting period (Q1 2026)
2026-03-11Approval of Special Use Permit for Midwest Regional Reception Center
2026-03-30California City facility litigation transferred to Eastern District of California
2026-03-31End of current reporting period (Q1 2026)
2026-04-01Acquisition of Clinical Solutions Pharmacy (CSP)
2026-04-09Maturity date of Incremental Term Loan
2026-05-07Date of filing of the 10-Q report

Recommendation

strong buy

The Q1 2026 results demonstrate a significant turnaround and strong execution, with substantial revenue and profit growth driven by increased federal demand and successful facility activations. The strategic acquisition of CSP and enhanced credit facilities position the company for continued growth and diversification. Despite some cost pressures and ongoing legal matters, the positive operational and financial trends, coupled with favorable industry tailwinds, warrant a strong buy recommendation.

Keywords

CoreCivic, 10-Q, Corrections, Detention, Residential Reentry, ICE, Federal Contracts, Occupancy, Revenue, Operating Expenses, Acquisition, Financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.